Oral cancer outcomes associated with proteasomal activator PA28γ
Access to the full content of this site is available only to registered healthcare professionals.
Register to read more
- High expression of the proteasomal activator PA28γ is associated with reduced survival of oral squamous cell carcinoma (OSCC) patients.
- In three separate cohorts, patients with high tumor expression of PA28γ had worse overall survival compared with low-expressing patients (p<.001, p<.001, and p=.003, respectively).
- Expression of PA28γ was also significantly associated with disease-free survival (p<.005 for all three cohorts).
- Addition of PA28γ to traditional clinical factors significantly improved prediction of all-cause mortality (p=.016...